Hcq 200 Tablet Indications

Hcq 200 Tablet is primarily indicated in conditions like Adjunctive treatment of cortical myoclonus, Dermatological diseases, Discoid and systemic lupus erythematosus, Juvenile chronic arthritis, Malaria, Malaria prophylaxis, Premenstrual syndrome, Prophylaxis of bipolar disorder, Prostate cancer (metastatic), flare with initial gonadorelin therapy, Rheumatoid arthritis, Systemic and discoid lupus erythematosus.

Contraindication

Hcq 200 Tablet is contraindicated in conditions like Psoriasis, Renal diseases, Hepatic disease, Retinopathy, G6pd deficiency,GI diseases, Neurological disorders, Blood disorders, Porphyria cutanea tarda.

Side Effects

The severe or irreversible adverse effects of Hcq 200 Tablet, which give rise to further complications include Retinotoxicity.Hcq 200 Tablet produces potentially life-threatening effects which include Cardiotoxicity. which are responsible for the discontinuation of Hcq 200 Tablet therapy. The signs and symptoms that are produced after the acute overdosage of Hcq 200 Tablet include Death, Convulsions, Headache, Cardiopulmonary arrest, Cardiovascular collapse, Visual distrubances. The symptomatic adverse reactions produced by Hcq 200 Tablet are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Ataxia, Nausea, Vomiting, Alopecia, Anorexia Diarrhea, Skin reactions, Abdominal cramps, Nervousness, Tinnitus, VertigoX, Psychosis, Bleaching of hair, Nightmares, Muscular weakness, Emotional upsets, Nerve deafness, Alopecia, nervousness, Nervousness, Ataxia.

Warnings

Hcq 200 Tablet should be used with caution in patients with kidney or liver disease, alcoholism or metabolic acidosis. Perform periodic blood count during prolong therapy, if severe blood disorder appears, discontinue therapy. It should be used with caution in patients with glucose 6 phosphate (G-6-PD) deficiency.Avoid in brest-feeding becouse of risk of toxicity in infants.